Prenatal cell ‐free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory

ConclusionThis cfDNA prenatal screening assay provides highly accurate discrimination between affected and unaffected pregnancies among a population of pregnant women at average and high risk for fetal genetic abnormalities.

Source: Molecular Genetics & Genomic Medicine - January 31, 2019 Category: Genetics & Stem Cells Authors: Carrie Guy, Farnoosh Haji ‐Sheikhi, Charles M. Rowland, Ben Anderson, Renius Owen, Felicitas L. Lacbawan, Damian P. Alagia Tags: ORIGINAL ARTICLE Source Type: research